RxSight (RXST) EBITDA Margin Growth (3y) (2023 - 2026)
RxSight (RXST) EBITDA Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -201.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 586.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 736.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 887.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 963.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 212.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 535.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 244.00 |
| 10 | RxSight | 250.81 Mn | -153.43 Mn | - | 2,457.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,457.00 |
| Mar 31, 2026 | -13,262.00 |
| Dec 31, 2025 | 5,852.00 |
| Sep 30, 2025 | -16,704.00 |
| Jun 30, 2025 | -18,071.00 |
| Mar 31, 2025 | 15,723.00 |
| Dec 31, 2024 | -110,065.00 |
| Sep 30, 2024 | -25,253.00 |
| Jun 30, 2024 | 25,959.00 |
| Mar 31, 2024 | 28,345.00 |
| Dec 31, 2023 | 35,120.00 |
| Sep 30, 2023 | -26,979.00 |
| Jun 30, 2023 | 39,056.00 |